Highlights the significant contribution of noncardiovascular death in heart failure patients, particularly those with preserved ejection fraction.
Noncardiovascular death warrants attention in HFpEF; leaves open need for targeted trials before changing practice.
Individuals with HF in the community often experience cardiovascular death, but noncardiovascular disease also contributes significantly especially among those with preserved LVEF.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: